ORIGINAL ARTICLERemote ischemic preconditioning inhibits platelet αIIbβ3 activation in coronary artery disease patients receiving dual antiplatelet therapy: A randomized trial
Keywords
Cited by (0)
Leonard Kritharides and Vivien M. Chen contributed equally to this work.
This work was carried out at Concord Hospital and the ANZAC Research Institute, Sydney, Australia.
This study is registered with the Australia and New Zealand Clinical Trials Registry (ACTRN12616000486426, www.anzctr.org.au).
Manuscript handled by: Yukio Ozaki
Final decision: Yukio Ozaki, 6 February 2020
Funding informationJKL was supported by an NHMRC/National Heart Foundation of Australia Postgraduate Scholarship (1094384). Equipment maintenance was supported by a Sydney Local Heath District Infrastructure Grant. Sponsors had no role in the study design, data analysis, data interpretation, or writing of the manuscript. There was no additional external funding received for this study.